Anti-BRAF/anti-MEK targeted therapies for metastatic melanoma patients during the COVID-19 outbreak: experience from an Italian skin cancer unit.
Pietro QuaglinoPaolo FavaMatteo BrizioElena MarraMarco RubattoMartina MerliLuca TonellaSimone RiberoMaria Teresa FierroPublished in: Future oncology (London, England) (2021)